公司代码：688399 公司简称：硕世生物 第一节重要提示 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到www.sse.com.cn网站仔细阅读半年度报告全文。 1.2重大风险提示 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险及应对措施，敬请查阅本报告第三 节"管理层讨论与分析"之"四、风险因素"。 1.3本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、完整 性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 1.4公司全体董事出席董事会会议。 1.5本半年度报告未经审计。 1.6董事会决议通过的本报告期利润分配预案或公积金转增股本预案 2025年8月7日，公司召开第三届董事会第十二次会议审议通过了《关于2025年半年度利润分配预案的议 案》，公司拟以实施权益分派股权登记日登记的总股本为基数，向全体股东每10股派发现金红利34.00 元（含税）。截至本公告披露日，公司总股本为83,871,721股，以此计算本次合计拟派发现金红利 285,163,851.40元（含税）。本次利润分 ...

Core Viewpoint - The company reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [2] Financial Performance - The company achieved an operating revenue of 175,580,501.65 yuan in the first half of 2025, representing a year-on-year decrease of 1.05% [2] - The net profit attributable to shareholders was 3,992,614.61 yuan, which reflects a significant year-on-year decline of 86.35% [2]

（文章来源：证券日报） 证券日报网讯 8月8日晚间，硕世生物发布公告称，公司第三届监事会第十次会议审议通过了《关于 2025年半年度报告及其摘要的议案》等多项议案。 ...

Group 1 - The company, Shuoshi Biotechnology, announced that it will hold its first extraordinary general meeting of shareholders for 2025 on August 27, 2025 [1] - The agenda for the meeting includes the review of the proposal regarding the profit distribution plan for the first half of 2025 [1]

按申万行业统计，硕世生物所属的医药生物行业共有5家公司公布了2025半年度分配方案，派现金额最 多的是药明康德，派现金额为10.03亿元，其次是硕世生物、九洲药业，派现金额分别为2.85亿元、1.76 亿元。（数据宝） 2025半年度医药生物行业分红排名 | 代码 | 简称 | 每10股送转 | 每10股派现 | 派现金额（万 | 派现占净利润比例 | 股息率 | | --- | --- | --- | --- | --- | --- | --- | | | | （股） | （元） | 元） | （%） | （%） | | 603259 | 药明康 德 | 0.00 | 3.5 | 100308.38 | 11.72 | 0.58 | | 688399 | 硕世生 物 | 0.00 | 34 | 28516.39 | 7142.28 | 5.17 | | 603456 | 九洲药 业 | 0.00 | 2 | 17634.20 | 33.54 | 1.42 | | --- | --- | --- | --- | --- | --- | --- | | 000915 | 华特达 因 | 0.00 | 5 | 1 ...

Group 1: Company Announcements - Puyuan Precision plans to issue H-shares and list on the Hong Kong Stock Exchange [4] - Wanxing Technology intends to issue H-shares and list on the Hong Kong Stock Exchange [11] - Liou Co. plans to use no more than 3 billion yuan of its own funds for securities investment [13] - Guangdong Hongda's subsidiary intends to acquire 60% equity of Changzhilin for 1.02 billion yuan [12] Group 2: Financial Performance and Investments - GSK Gas plans to use 350 million yuan of raised funds for the Wuhan GSK Semiconductor Electronic Gas Station project, with a total investment of 503 million yuan [3] - Lianyungang's wholly-owned subsidiary plans to invest 548.8 million yuan in shipbuilding [2] - Hongjing Optoelectronics plans to invest 1.533 billion yuan in the construction of its R&D and manufacturing headquarters [9] Group 3: Regulatory Issues - Jihua Group is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [7] - *ST Gaohong may face forced delisting due to major violations related to fraudulent issuance of shares and false records in annual reports from 2015 to 2023 [8] Group 4: Sales Performance - Jingji Zhinnong reported sales of 3.51 billion yuan from selling 203,600 pigs in July, with a cumulative sales revenue of 2.243 billion yuan from January to July [8] - Zhengbang Technology reported sales of 7.41 billion yuan from selling 695,200 pigs in July, with a cumulative sales revenue of 4.818 billion yuan from January to July, showing significant year-on-year growth [10] Group 5: Share Transfers - Anzheng Fashion's shareholder plans to transfer 5.35% of the company's shares at a price of 6.78 yuan per share, totaling 141 million yuan [5] - Bidetech's actual controller and associates plan to transfer 29.9% of the company's shares to Dinglong Qishun for 897 million yuan [6]

Group 1: Investment Announcements - Panjiang Co. plans to increase investment by 55.8 million yuan in its wholly-owned subsidiary, New Energy Zhenning Co., for the construction of a wind power project with a total investment of 279 million yuan [1] - Lianyungang's wholly-owned subsidiary, Yunport Ferry Co., intends to invest 548.8 million yuan in building a passenger and vehicle ferry, having signed a construction contract with Huanghai Shipbuilding Co. [1] - Guanggang Gas plans to use 350 million yuan of raised funds for the Wuhan Guanggang Semiconductor Electronic Gas Station project, with a total planned investment of 503 million yuan [1] - Hongjing Optoelectronics intends to invest in a new R&D and manufacturing headquarters with a total investment of 1.533 billion yuan [6] Group 2: Share Transfers - Anzheng Fashion's shareholder plans to transfer 5.35% of the company's shares, totaling 20.8 million shares at a price of 6.78 yuan per share, amounting to 141 million yuan [2] - Bidetech's actual controllers plan to transfer 29.9% of the company's shares, totaling 56.1672 million shares at a price of 15.97 yuan per share, amounting to 897 million yuan [3] Group 3: Financial Performance - Jingji Zhino reported sales of 203,600 pigs in July, generating revenue of 351 million yuan, with a cumulative sales revenue of 2.243 billion yuan from January to July [6] - Zhengbang Technology reported sales of 695,200 pigs in July, with a revenue of 741 million yuan, showing a year-on-year increase of 91.38% and a cumulative revenue of 4.818 billion yuan from January to July [6] - Shuoshi Bio reported a 1.05% decrease in revenue to 176 million yuan for the first half of the year, with a net profit decline of 86.35% to 3.9926 million yuan [9] Group 4: Regulatory Issues - Jihua Group is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [4] - *ST Gaohong received a notice indicating potential major illegal delisting due to fraudulent issuance of shares and false records in annual reports from 2015 to 2023 [4] Group 5: Other Announcements - Wanjing Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [7] - Guangdong Hongda's subsidiary intends to acquire 60% of Changzhilin for 1.02 billion yuan, enhancing its defense equipment business [7] - Lio Co. approved a plan to use up to 3 billion yuan of its own funds for securities investments [8]

Core Points - The company Shuoshi Bio (688399) reported a revenue of 176 million yuan for the first half of 2025, representing a year-on-year decrease of 1.05% [2] - The net profit attributable to the company was 3.99 million yuan, down 86.35% compared to the same period last year [2] Financial Performance - The decline in net profit is primarily attributed to the pressure on product prices due to the deep implementation of centralized procurement in the in vitro diagnostic industry across the country [2] - An adjustment in the value-added tax rate for self-produced testing reagents to 13% contributed to the decrease in gross margin [2] - There was a reduction in the reversal of impairment provisions for receivables and a decrease in government subsidies during the reporting period [2]

江苏硕世生物科技股份有限公司 第三届监事会第十次会议决议公告 证券代码：688399 证券简称：硕世生物 公告编号：2025-021 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏硕世生物科技股份有限公司（以下简称"公司"）于 2025 年 8 月 7 日 议"）。本次会议通知于 2025 年 7 月 27 日向各位监事发出，本次会议应到监 事 3 人，实到监事 3 人。本次会议的召集、召开程序均符合《公司法》《证券 法》等法律、法规和规范性文件以及《公司章程》的规定。 会议由监事会主席马施达先生主持，经与会监事充分讨论，会议以记名投 票方式审议通过了如下议案： 一、审议通过《关于 2025 年半年度报告及其摘要的议案》； 监事会认为：公司 2025 年半年度报告及摘要的编制和审议程序符合相关法 律、法规及《公司章程》等相关规定，公司编制的 2025 年半年度报告内容公允 地反映了公司 2025 年半年度的财务状况和经营成果等事项，信息真实、准确、 完整，不存在任何虚假记载、误导性陈述或重大遗漏。 表决结果：同意 3 ...

江苏硕世生物科技股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 证券代码：688399 证券简称：硕世生物 公告编号：2025-028 召开日期时间：2025 年 8 月 27 日 13 点 30 分 召开地点：江苏省泰州市药城大道 837 号公司会议室 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 （六） 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票，应按照《上海证券交易所科创板上市公司自律监管指引第 1 号 — 规范运作》 等有关规定执行。 （七） 涉 ...